Vaccine Effectiveness against SARS-CoV-2 Variant P.1 in Nursing-Facility Residents, Washington, USA, April 2021.

Lewis, James W; Loughran, Julie; Deng, Li; Varghese, Jasmine; Clark, Shauna; Harrison, Casandra; Gacetta, Molly; Jernigan, John A; Fleming-Dutra, Katherine E

Lewis, James W; Loughran, Julie; Deng, Li; Varghese, Jasmine; Clark, Shauna; Harrison, Casandra; Gacetta, Molly; Jernigan, John A; Fleming-Dutra, Katherine E.

Emerg Infect Dis ; 28(11): 2338-2341, 2022 11.

Article em En | MEDLINE | ID: mdl-36170764

ABSTRACT

ABSTRACT

A SARS-CoV-2 P.1 (Gamma) variant outbreak occurred at a skilled nursing facility in Washington, USA, in April 2021. Effectiveness of 2 doses of mRNA vaccines against P.1 infection among residents in this outbreak was 75.0% (95% CI 44.5%-88.7%), similar to effectiveness for other pre-Delta variants among long-term care residents.

Assuntos

COVID-19; SARS-CoV-2; Humanos; SARS-CoV-2/genética; Washington/epidemiologia; Eficácia de Vacinas; COVID-19/epidemiologia; COVID-19/prevenção & controle

Palavras-chave

COVID-19; P.1; SARS-CoV-2; United States; coronavirus disease; long-term care; respiratory infections; severe acute respiratory syndrome coronavirus 2; vaccine effectiveness; viruses; zoonoses

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Emerg Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google